QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy-Reference-Cited by-同舟云学术

QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy

Published:2018-12 Issue:12 Volume:11 Page:
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

van Stipdonk Antonius M.W.¹,ter Horst Iris¹²,Kloosterman Marielle³,Engels Elien B.⁴,Rienstra Michiel³,Crijns Harry J.G.M.¹⁴,Vos Marc A.⁵,van Gelder Isabelle C.³,Prinzen Frits W.⁴,Meine Mathias²,Maass Alexander H.³,Vernooy Kevin¹⁴⁶

Affiliation:

1. Department of Cardiology, Maastricht University Medical Centre, The Netherlands (A.M.W.v.S., H.J.G.M.C., K.V.).

2. Department of Cardiology, University Medical Centre Utrecht, The Netherlands (I.t.H., M.M.).

3. Department of Cardiology, University Medical Centre Groningen, University of Groningen, The Netherlands (M.K., M.R., I.C.v.G., A.H.M.).

4. Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands (E.B.E., H.J.G.M.C., F.W.P., K.V.).

5. Department of Medical Physiology, University of Utrecht, The Netherlands (M.A.V.).

6. Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands (K.V.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Cardiac Resynchronization in Chronic Heart Failure

2. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

3. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management: A registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society; and in collaboration with the Heart Failure Society of America (HFSA), the American Society of Echocardiography (ASE), the American Heart Association (AHA), the European Association of Echocardiography (EAE) of the ESC and the Heart Failure Association of the ESC (HFA). * Endorsed by the governing bodies of AHA, ASE, EAE, HFSA, HFA, EHRA, and HRS

4. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

5. Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of myocardial injury by serial measurements of QRS area and T area: The MaastrICCht cohort;Annals of Noninvasive Electrocardiology;2024-09

2. New Pacing Techniques and Non-Invasive Methods That May Improve Response to Cardiac Resynchronization Therapy;Journal of Cardiovascular Development and Disease;2024-07-03

3. Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review;Heart Rhythm;2024-06

4. Pilot study to evaluate left‐to‐right ventricular offset in biventricular pacing—comparison of electrocardiographic imaging and ECG;Journal of Cardiovascular Electrophysiology;2024-04-09

5. Different methods of 3D QRS area calculation from vectorcardiographic X, Y, and Z Leads;Pacing and Clinical Electrophysiology;2024-03-26